EUVIMEDEUVIMED entdecken
Crossref

Ms4a7 expression in cDC1s determines cross-presentation and antitumor immunity

Bowen Xie iD, Bowen Yuan iD, Xiaohong Zhao, Tian Xie, Ruifeng Li, Peng Wei iD, Qinli Sun iD, Wenbo Hu, Birui Pan, Yongzhen Chen iD, Kun Wei, Zixuan Zhao und 7 weitere

Science · 13.11.2025 · 390 (6774)

DOI: 10.1126/science.ady5362 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, erschienen am 13.11.2025. Verfasst von Bowen Xie und 18 weiteren Autor:innen. Beteiligte Einrichtung: Westlake University School of Medicine, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Cross-Priming, Dendritic Cells, Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 82 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Conventional type 1 dendritic cells (cDC1s) capture antigens in peripheral tissues and migrate to draining lymph nodes (dLNs) to prime antigen-specific CD8 + T cells. How tumor antigens are processed to activate CD8 + T cell immunity is not well understood. In this work, we show that Ms4a7 is up-regulated in cDC1s after tumor antigen uptake or exposure to exogenous stimuli and is required for their cross-priming ability. Although Ms4a7 −/− mice showed normal cDC1 development and turnover, they failed to prime antigen-specific CD8 + T cells following infection or tumor development. In human cancers, MS4A7 was expressed in a subset of cDC1s, preferentially enriched in dLNs, and correlated with patient survival. Our findings suggest a critical role for Ms4a7 in cDC1-mediated cross-presentation and antitumor CD8 + T cell responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesCross-PrimingDendritic CellsNeoplasmsMembrane ProteinsAntigens, CD20AnimalsHumansMiceAntigens, NeoplasmCell Line, TumorLymph NodesMice, Inbred C57BLMice, KnockoutUp-Regulation

Substanzen

Antigens, NeoplasmMS4A7 protein, humanMembrane ProteinsAntigens, CD20

Autor:innen und Institutionen

  • Westlake University School of Medicine, Hangzhou, Zhejiang, China.
  • Institute for Immunology and School of Medicine, Tsinghua University, Beijing, China.
  • Tsinghua-Peking Center for Life Sciences, Tsinghua University, Beijing, China.
  • Department of Pathology, The Third Xiangya Hospital, Central South University, Changsha, China.

ORCID-Profile: Bowen Xie, Bowen Yuan, Peng Wei, Qinli Sun, Yongzhen Chen, Xuan Zhong, Xue Bai, Qiuyan Lan, Ling Ni, Chen Dong

Zitieren

APA

Xie, B., Yuan, B., Zhao, X., Xie, T., Li, R., Wei, P., Sun, Q., Hu, W., Pan, B., Chen, Y., Wei, K., Zhao, Z., Yuan, L., Zhong, X., Bai, X., Lan, Q., Qin, L., Ni, L., & Dong, C. (2025). Ms4a7 expression in cDC1s determines cross-presentation and antitumor immunity. Science, 390(6774). https://doi.org/10.1126/science.ady5362

Vancouver

Xie B, Yuan B, Zhao X, Xie T, Li R, Wei P, et al. Ms4a7 expression in cDC1s determines cross-presentation and antitumor immunity. Science. 2025;390(6774). doi:10.1126/science.ady5362

BibTeX
@article{Xie2025,
  author = {Xie, Bowen and Yuan, Bowen and Zhao, Xiaohong and Xie, Tian and Li, Ruifeng and Wei, Peng and Sun, Qinli and Hu, Wenbo and Pan, Birui and Chen, Yongzhen and Wei, Kun and Zhao, Zixuan and Yuan, Lei and Zhong, Xuan and Bai, Xue and Lan, Qiuyan and Qin, Lei and Ni, Ling and Dong, Chen},
  title = {Ms4a7 expression in cDC1s determines cross-presentation and antitumor immunity},
  journal = {Science},
  year = {2025},
  volume = {390},
  number = {6774},
  doi = {10.1126/science.ady5362}
}
Kostenlos starten →